The Archer® FusionPlex® Acute Lymphoblastic Leukemia (ALL) Kit is a targeted next-generation sequencing assay to detect and identify fusions, point mutations and expression levels in 81 genes associated with Acute Lymphoblastic Leukemia, including recurrent Ph-Like ALL fusion events. The kit uses Archer’s proprietary Anchored Multiplex PCR (AMP™)-based enrichment to detect fusions, even without prior knowledge of fusion partners or breakpoints.
Acute Lymphocytic Leukemia
ABL1 (ABL proto-oncogene 1), ABL2 (ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase), BCL11B (BAF Chromatin Remodeling Complex Subunit BCL11B), BCL2 (B-cell CLL/lymphoma 2), BCL6 (B-cell CLL/lymphoma 6), BRAF (B-raf proto-oncogene)
See More ...
Next-Generation Sequencing (NGS)